AGA Rejects ABIM’s Proposed MOC Pathways

ABIM proposes to replace the 10-year exam with either a two or five year alternative MOC Pathway.

Flex Your Endorsement Muscle

What's the Cause of This Patient's GI Ulcers?

Tip for GI Fellows: Be a Sponge

AGA Rejects ABIM’s Proposed MOC Pathways

Flex Your Endorsement Muscle

What's the Cause of This Patient's GI Ulcers?

Tip for GI Fellows: Be a Sponge

News

Filter
  • All
  • Celiac Disease
  • Colorectal Cancer
  • Endoscopy
  • GERD
  • Hepatitis C
  • IBD
  • Advocacy
  • Cancer prevention and treatment
  • GI practice & quality
  • Gut Microbiome & FMT
  • Hepatology
  • Lower GI disorders & procedures
  • Obesity & nutrition
  • Pancreaticobiliary disorders & procedures
  • Pediatric Gastroenterology
  • Procedures
  • Regulatory Peptides, Cell Signaling & Molecular Biology
  • Upper GI disorders & procedures

Gastroenterology

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

Sept. 27, 2016

Using MRC analysis of patients with long-term IBD, we found the prevalence of PSC to be around 3-fold higher than that detected based on symptoms.

Gastroenterology

Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen

Sept. 27, 2016

We assessed the presence of hepatitis C virus RNA in liver explants from 39 patients awaiting liver transplantation who were treated with an interferon-free regimen and had undetectable serum HCV RNA at the time of liver transplantation.

Gastroenterology

Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families

Sept. 27, 2016

We studied 2 large Ashkenazi Jewish families with a high prevalence of CD in an attempt to identify novel genetic risk variants.

News

Flex Your Endorsement Muscle

Sept. 27, 2016

Use the 'recommend' button in AGA Community to endorse a response and boost its value to the discussion author.

News

Have a Topic in Mind for the 2018 Freston Conference?

Sept. 27, 2016

Send in your suggestions for the next James W. Freston conference by Jan. 6, 2017.

Gastroenterology

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity

Sept. 27, 2016

We investigated gluten metabolism by opportunistic pathogens and commensal duodenal bacteria and characterized the capacity of the produced peptides to activate gluten-specific T-cells from CD patients.

Gastroenterology

ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer

Sept. 27, 2016

Emerging evidence suggests a role for RNA editing and ADARs in cancer, however, the relationship between RNA editing and GC development and progression remains unknown.
Advertisement

Gastroenterology

High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis

Sept. 27, 2016

In cirrhotic HCV GT1- or GT3-infected patients, ABT-493 plus ABT-530 with or without RBV achieved SVR12 rates of 96%–100% and was well tolerated.